Myant's Acquisition of mmHg Inc. Pushes Forward Precision Medicine in Cardiovascular Care
Myant's Strategic Acquisition of mmHg Inc.
In a significant move aimed at revolutionizing cardiovascular health management, Myant Corp., a frontrunner in the field of precision medicine for chronic disease prevention, has announced its acquisition of mmHg Inc., a digital health company specializing in remote blood pressure monitoring, cardiovascular risk assessment, and chronic illness management. This acquisition marks a pivotal expansion of Myant's operational scope, particularly in the United States, where mmHg boasts a robust customer base, including a partnership with the prestigious AD Medical, a leading manufacturer of accurate medical devices and health products.
This acquisition is not merely a financial transaction; it represents a shift toward a new era of healthcare characterized by
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.